好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Congenital Neuromuscular Disease with Uniform Type 1 Fiber Due to RYR1 Mutations
Muscle Disease/Neuromuscular Junction
(-)
039
Authors/Disclosures
Ichizo Nishino, MD, PhD, FAAN (National Institute of Neuroscience, NCNP) The institution of Dr. Nishino has received research support from AMED.
Douglas M. Smith, MD (Minnesota Epilepsy Group) Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pyros Pharma. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher-Smith. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Shin J. Oh, MD, FAAN No disclosure on file
No disclosure on file
No disclosure on file